Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX)
CAPS Rating:
A biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases.
RSS Headlines
Fool UK
Recs
biotech plays that zzlangerhans is behind on & picks that the CAPs community agrees with via star rating.
GREENthumb: ARNA, PGNX, ARRY, GENZ, CEPH, CPD, MYGN, ELN
REDthumb: PLX, ITMN, CLDA, PCYC